Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Clay B Siegall. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Clay B Siegall har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:STTK / Shattuck Labs, Inc. | Director | 128 054 |
US:IMNM / Immunome, Inc. | President and CEO, Director | 806 736 |
US:SGEN / Seagen Inc | President & CEO, Director | 51 129 |
US:NRIX / Nurix Therapeutics, Inc. | Director | 17 500 |
US:RARE / Ultragenyx Pharmaceutical Inc. | Director | 0 |
US:ALDR / Alder BioPharmaceuticals, Inc. | Director | 0 |
US:MIRN / Mirna Therapeutics, Inc. | Director | 10 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Clay B Siegall. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IMNM / Immunome, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IMNM / Immunome, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IMNM / Immunome, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp NRIX / Nurix Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IMNM / Immunome, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IMNM / Immunome, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp STTK / Shattuck Labs, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IMNM / Immunome, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IMNM / Immunome, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp SYBX / Synlogic, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IMNM / Immunome, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IMNM / Immunome, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Clay B Siegall som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-27 |
|
4 | STTK |
Shattuck Labs, Inc.
Common Stock |
A - Award | 128 054 | 128 054 | 0,87 | 111 112 | 111 112 | ||
2025-03-26 |
|
4 | IMNM |
Immunome Inc.
Common Stock |
P - Purchase | 137 100 | 806 736 | 20,47 | 7,29 | 999 459 | 5 881 105 | |
2025-02-03 |
|
4 | IMNM |
Immunome Inc.
Common Stock |
P - Purchase | 150 000 | 669 636 | 28,87 | 7,75 | 1 162 500 | 5 189 679 | |
2024-11-25 |
|
4 | IMNM |
Immunome Inc.
Common Stock |
P - Purchase | 33 943 | 519 636 | 6,99 | 9,78 | 331 918 | 5 081 365 | |
2024-11-25 |
|
4 | IMNM |
Immunome Inc.
Common Stock |
P - Purchase | 66 057 | 485 693 | 15,74 | 9,54 | 630 263 | 4 634 094 | |
2024-05-21 |
|
4 | IMNM |
Immunome Inc.
Common Stock |
P - Purchase | 20 434 | 419 636 | 5,12 | 13,78 | 281 548 | 5 781 913 | |
2024-05-21 |
|
4 | IMNM |
Immunome Inc.
Common Stock |
P - Purchase | 79 566 | 399 202 | 24,89 | 13,91 | 1 106 524 | 5 551 702 | |
2023-10-04 | 3 | IMNM |
Immunome Inc.
Common Stock |
150 432 | ||||||||
2023-10-04 |
|
4 | IMNM |
Immunome Inc.
Common Stock |
P - Purchase | 169 204 | 319 636 | 112,48 | 5,91 | 999 996 | 1 889 049 | |
2022-05-13 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 593 | 51 129 | −17,16 | ||||
2022-05-13 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 450 | 61 722 | −9,46 | ||||
2022-05-13 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −10 593 | 666 060 | −1,57 | 125,39 | −1 328 256 | 83 517 263 |
2022-05-13 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 10 593 | 676 653 | 1,59 | 26,10 | 276 477 | 17 660 643 | |
2022-05-13 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −6 450 | 666 060 | −0,96 | 126,18 | −813 861 | 84 043 451 |
2022-05-13 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 450 | 672 510 | 0,97 | 26,10 | 168 345 | 17 552 511 | |
2022-05-06 |
|
4 | NRIX |
Nurix Therapeutics, Inc.
Director Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2022-04-22 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 885 | 666 060 | −0,28 | 144,32 | −272 041 | 96 124 847 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −474 | 68 172 | −0,69 | ||||
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 900 | 68 646 | −2,69 | ||||
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 828 | 70 546 | −5,15 | ||||
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 400 | 74 374 | −3,13 | ||||
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 692 | 76 774 | −5,76 | ||||
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 100 | 81 466 | −2,51 | ||||
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 649 | 83 566 | −1,94 | ||||
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −474 | 667 945 | −0,07 | 157,23 | −74 527 | 105 020 992 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 474 | 668 419 | 0,07 | 26,10 | 12 371 | 17 445 736 | |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 900 | 667 945 | −0,28 | 156,48 | −297 312 | 104 520 034 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 900 | 669 845 | 0,28 | 26,10 | 49 590 | 17 482 954 | |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 828 | 667 945 | −0,57 | 155,83 | −596 517 | 104 085 869 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 828 | 671 773 | 0,57 | 26,10 | 99 911 | 17 533 275 | |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 400 | 667 945 | −0,36 | 154,36 | −370 464 | 103 103 990 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 400 | 670 345 | 0,36 | 26,10 | 62 640 | 17 496 004 | |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 692 | 667 945 | −0,70 | 153,38 | −719 659 | 102 449 404 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 692 | 672 637 | 0,70 | 26,10 | 122 461 | 17 555 826 | |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 100 | 667 945 | −0,31 | 152,59 | −320 439 | 101 921 728 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 100 | 670 045 | 0,31 | 26,10 | 54 810 | 17 488 174 | |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 649 | 667 945 | −0,25 | 151,42 | −249 692 | 101 140 232 |
2022-04-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 649 | 669 594 | 0,25 | 26,10 | 43 039 | 17 476 403 | |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 85 215 | −4,48 | ||||
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 643 | 89 215 | −6,93 | ||||
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 400 | 95 858 | −2,44 | ||||
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 900 | 98 258 | −3,82 | ||||
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −100 | 102 158 | −0,10 | ||||
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 000 | 667 945 | −0,60 | 135,62 | −542 480 | 90 586 701 |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 000 | 671 945 | 0,60 | 26,10 | 104 400 | 17 537 764 | |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −6 643 | 667 945 | −0,98 | 134,74 | −895 078 | 89 998 909 |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 643 | 674 588 | 0,99 | 26,10 | 173 382 | 17 606 747 | |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 400 | 667 945 | −0,36 | 133,69 | −320 856 | 89 297 567 |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 400 | 670 345 | 0,36 | 26,10 | 62 640 | 17 496 004 | |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 900 | 667 945 | −0,58 | 132,72 | −517 608 | 88 649 660 |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 900 | 671 845 | 0,58 | 26,10 | 101 790 | 17 535 154 | |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −100 | 667 945 | −0,01 | 136,33 | −13 633 | 91 060 942 |
2022-03-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 100 | 668 045 | 0,01 | 26,10 | 2 610 | 17 435 974 | |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −300 | 102 258 | −0,29 | ||||
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 084 | 102 558 | −3,83 | ||||
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 985 | 106 642 | −7,77 | ||||
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 574 | 115 627 | −3,00 | ||||
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −100 | 119 201 | −0,08 | ||||
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −300 | 667 945 | −0,04 | 141,56 | −42 468 | 94 554 294 |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 300 | 668 245 | 0,04 | 26,10 | 7 830 | 17 441 194 | |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 084 | 667 945 | −0,61 | 140,83 | −575 150 | 94 066 694 |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 084 | 672 029 | 0,61 | 26,10 | 106 592 | 17 539 957 | |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −8 985 | 667 945 | −1,33 | 139,96 | −1 257 541 | 93 485 582 |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 985 | 676 930 | 1,35 | 26,10 | 234 508 | 17 667 873 | |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 574 | 667 945 | −0,53 | 138,97 | −496 679 | 92 824 317 |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 574 | 671 519 | 0,54 | 26,10 | 93 281 | 17 526 646 | |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −100 | 667 945 | −0,01 | 137,29 | −13 729 | 91 702 169 |
2022-02-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 100 | 668 045 | 0,01 | 26,10 | 2 610 | 17 435 974 | |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 163 | 119 301 | −6,40 | ||||
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 560 | 127 464 | −3,45 | ||||
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 221 | 132 024 | −2,38 | ||||
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 100 | 135 245 | −0,81 | ||||
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −8 163 | 667 945 | −1,21 | 143,91 | −1 174 737 | 96 123 965 |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 163 | 676 108 | 1,22 | 26,10 | 213 054 | 17 646 419 | |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 560 | 667 945 | −0,68 | 144,82 | −660 379 | 96 731 795 |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 560 | 672 505 | 0,68 | 26,10 | 119 016 | 17 552 380 | |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 221 | 667 945 | −0,48 | 145,84 | −469 751 | 97 413 099 |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 221 | 671 166 | 0,48 | 26,10 | 84 068 | 17 517 433 | |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 100 | 667 945 | −0,16 | 147,16 | −161 876 | 98 294 786 |
2022-01-11 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 100 | 669 045 | 0,16 | 26,10 | 28 710 | 17 462 074 | |
2021-12-22 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 227 | 667 945 | −0,18 | 149,85 | −183 866 | 100 091 558 |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 348 | 136 345 | −3,77 | ||||
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 522 | 141 693 | −7,52 | ||||
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −14 691 | 153 215 | −8,75 | ||||
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −12 238 | 167 906 | −6,79 | ||||
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 650 | 180 144 | −0,91 | ||||
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −5 348 | 669 172 | −0,79 | 150,38 | −804 232 | 100 630 085 |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 5 348 | 674 520 | 0,80 | 26,10 | 139 583 | 17 604 972 | |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −11 522 | 669 172 | −1,69 | 149,56 | −1 723 230 | 100 081 364 |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 11 522 | 680 694 | 1,72 | 26,10 | 300 724 | 17 766 113 | |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −14 691 | 669 172 | −2,15 | 148,27 | −2 178 235 | 99 218 132 |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 14 691 | 683 863 | 2,20 | 26,10 | 383 435 | 17 848 824 | |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −12 238 | 669 172 | −1,80 | 147,83 | −1 809 144 | 98 923 697 |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 12 238 | 681 410 | 1,83 | 26,10 | 319 412 | 17 784 801 | |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 650 | 669 172 | −0,25 | 146,54 | −241 791 | 98 060 465 |
2021-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 650 | 670 822 | 0,25 | 26,10 | 43 065 | 17 508 454 | |
2021-09-27 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 714 | 669 172 | 0,11 | 166,22 | 118 681 | 111 229 770 | |
2021-09-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 787 | 668 458 | −0,71 | 167,52 | −801 897 | 111 977 076 |
2021-09-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −9 564 | 673 245 | −1,40 | 167,52 | −1 602 118 | 112 778 973 |
2021-08-31 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | −8 662 | 682 809 | −1,25 | 170,27 | −1 474 879 | 116 261 888 | |
2021-08-31 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | −1 770 | 691 471 | −0,26 | 168,19 | −297 696 | 116 298 507 | |
2021-08-31 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | −2 906 | 693 241 | −0,42 | 167,62 | −487 104 | 116 201 056 | |
2021-08-31 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | −32 800 | 696 147 | −4,50 | 166,79 | −5 470 712 | 116 110 358 | |
2021-08-31 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | −2 081 | 728 947 | −0,28 | 170,16 | −354 103 | 124 037 622 | |
2021-08-31 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | −12 213 | 731 028 | −1,64 | 168,86 | −2 062 287 | 123 441 388 | |
2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 74 549 | 74 549 | |||||
2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Incentive Stock Option (right to buy) |
A - Award | 642 | 642 | |||||
2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 30 821 | 743 241 | 4,33 | ||||
2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 789 | 712 420 | −0,39 | 154,55 | −431 051 | 110 107 361 |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 676 | 0 | −100,00 | ||||
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 117 | 3 676 | −36,54 | ||||
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 676 | 715 209 | −0,51 | 159,26 | −585 440 | 113 904 185 |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 676 | 718 885 | 0,51 | 15,46 | 56 831 | 11 113 962 | |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 117 | 715 209 | −0,30 | 160,46 | −339 694 | 114 762 436 |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 117 | 717 326 | 0,30 | 15,46 | 32 729 | 11 089 860 | |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 185 | 5 793 | −55,36 | ||||
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 262 | 12 978 | −41,65 | ||||
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 813 | 22 240 | −17,79 | ||||
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 300 | 27 053 | −7,84 | ||||
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −7 185 | 715 209 | −0,99 | 162,02 | −1 164 114 | 115 878 162 |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 7 185 | 722 394 | 1,00 | 15,46 | 111 080 | 11 168 211 | |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −9 262 | 715 209 | −1,28 | 163,10 | −1 510 632 | 116 650 588 |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 9 262 | 724 471 | 1,30 | 15,46 | 143 191 | 11 200 322 | |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 813 | 715 209 | −0,67 | 163,80 | −788 369 | 117 151 234 |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 813 | 720 022 | 0,67 | 15,46 | 74 409 | 11 131 540 | |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 300 | 715 209 | −0,32 | 164,77 | −378 971 | 117 844 987 |
2021-08-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 300 | 717 509 | 0,32 | 15,46 | 35 558 | 11 092 689 | |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 191 | 29 353 | −15,03 | ||||
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 412 | 34 544 | −17,67 | ||||
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 355 | 41 956 | −5,31 | ||||
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −310 | 44 311 | −0,69 | ||||
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −5 191 | 715 209 | −0,72 | 155,70 | −808 239 | 111 358 041 |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 5 191 | 720 400 | 0,73 | 15,46 | 80 253 | 11 137 384 | |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −7 412 | 715 209 | −1,03 | 156,43 | −1 159 459 | 111 880 144 |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 7 412 | 722 621 | 1,04 | 15,46 | 114 590 | 11 171 721 | |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 355 | 715 209 | −0,33 | 157,31 | −370 465 | 112 509 528 |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 355 | 717 564 | 0,33 | 15,46 | 36 408 | 11 093 539 | |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −310 | 715 209 | −0,04 | 158,29 | −49 070 | 113 210 433 |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 310 | 715 519 | 0,04 | 15,46 | 4 793 | 11 061 924 | |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 488 | 44 621 | −9,14 | ||||
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 165 | 49 109 | −11,15 | ||||
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 432 | 55 274 | −5,85 | ||||
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 488 | 715 209 | −0,62 | 156,94 | −704 347 | 112 244 900 |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 488 | 719 697 | 0,63 | 15,46 | 69 384 | 11 126 516 | |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −6 165 | 715 209 | −0,85 | 157,92 | −973 577 | 112 945 805 |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 165 | 721 374 | 0,86 | 15,46 | 95 311 | 11 152 442 | |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 432 | 715 209 | −0,48 | 158,64 | −544 452 | 113 460 756 |
2021-07-06 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 432 | 718 641 | 0,48 | 15,46 | 53 059 | 11 110 190 | |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 843 | 58 706 | −3,04 | ||||
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 718 | 60 549 | −8,63 | ||||
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 675 | 66 267 | −11,58 | ||||
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 900 | 74 942 | −4,95 | ||||
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 551 | 78 842 | −5,46 | ||||
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 866 | 83 393 | −4,43 | ||||
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −800 | 87 259 | −0,91 | ||||
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 843 | 715 209 | −0,26 | 142,07 | −261 835 | 101 609 743 |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 843 | 717 052 | 0,26 | 15,46 | 28 493 | 11 085 624 | |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −5 718 | 715 209 | −0,79 | 142,99 | −817 617 | 102 267 735 |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 5 718 | 720 927 | 0,80 | 15,46 | 88 400 | 11 145 531 | |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −8 675 | 715 209 | −1,20 | 143,81 | −1 247 552 | 102 854 206 |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 675 | 723 884 | 1,21 | 15,46 | 134 116 | 11 191 247 | |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 900 | 715 209 | −0,54 | 144,90 | −565 110 | 103 633 784 |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 900 | 719 109 | 0,55 | 15,46 | 60 294 | 11 117 425 | |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 551 | 715 209 | −0,63 | 145,73 | −663 217 | 104 227 408 |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 551 | 719 760 | 0,64 | 15,46 | 70 358 | 11 127 490 | |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 866 | 715 209 | −0,54 | 147,00 | −568 302 | 105 135 723 |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 866 | 719 075 | 0,54 | 15,46 | 59 768 | 11 116 900 | |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −800 | 715 209 | −0,11 | 147,71 | −118 168 | 105 643 521 |
2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 800 | 716 009 | 0,11 | 15,46 | 12 368 | 11 069 499 | |
2021-06-01 |
|
4 | NRIX |
Nurix Therapeutics, Inc.
Director Stock Option (right to buy) |
A - Award | 35 000 | 35 000 | |||||
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 723 | 88 059 | −8,06 | ||||
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −18 079 | 95 782 | −15,88 | ||||
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 551 | 113 861 | −3,02 | ||||
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −7 723 | 715 209 | −1,07 | 134,29 | −1 037 122 | 96 045 417 |
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 7 723 | 722 932 | 1,08 | 15,46 | 119 398 | 11 176 529 | |
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −18 079 | 715 209 | −2,47 | 135,11 | −2 442 654 | 96 631 888 |
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 18 079 | 733 288 | 2,53 | 15,46 | 279 501 | 11 336 632 | |
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 551 | 715 209 | −0,49 | 135,75 | −482 048 | 97 089 622 |
2021-05-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 551 | 718 760 | 0,50 | 15,46 | 54 898 | 11 112 030 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 101 | 117 412 | −4,94 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 192 | 123 513 | −4,03 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 009 | 128 705 | −0,78 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −300 | 129 714 | −0,23 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −6 101 | 715 209 | −0,85 | 141,42 | −862 803 | 101 144 857 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 101 | 721 310 | 0,85 | 15,46 | 94 321 | 11 151 453 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −5 192 | 715 209 | −0,72 | 142,22 | −738 406 | 101 717 024 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 5 192 | 720 401 | 0,73 | 15,46 | 80 268 | 11 137 399 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 009 | 715 209 | −0,14 | 143,24 | −144 529 | 102 446 537 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 009 | 716 218 | 0,14 | 15,46 | 15 599 | 11 072 730 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −300 | 715 209 | −0,04 | 143,95 | −43 185 | 102 954 336 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 300 | 715 509 | 0,04 | 15,46 | 4 638 | 11 061 769 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 167 | 130 014 | −6,59 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 545 | 139 181 | −1,80 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 739 | 141 726 | −3,24 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −300 | 146 465 | −0,20 | ||||
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −9 167 | 715 209 | −1,27 | 144,40 | −1 323 715 | 103 276 180 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 9 167 | 724 376 | 1,28 | 15,46 | 141 722 | 11 198 853 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 545 | 715 209 | −0,35 | 145,43 | −370 119 | 104 012 845 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 545 | 717 754 | 0,36 | 15,46 | 39 346 | 11 096 477 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 739 | 715 209 | −0,66 | 146,41 | −693 837 | 104 713 750 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 739 | 719 948 | 0,66 | 15,46 | 73 265 | 11 130 396 | |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −300 | 715 209 | −0,04 | 147,15 | −44 145 | 105 243 004 |
2021-04-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 300 | 715 509 | 0,04 | 15,46 | 4 638 | 11 061 769 | |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 409 | 146 765 | −7,21 | ||||
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 447 | 158 174 | −5,64 | ||||
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 000 | 167 621 | −3,46 | ||||
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 497 | 173 621 | −1,42 | ||||
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −11 409 | 715 209 | −1,57 | 144,92 | −1 653 392 | 103 648 088 |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 11 409 | 726 618 | 1,60 | 15,46 | 176 383 | 11 233 514 | |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −9 447 | 715 209 | −1,30 | 145,58 | −1 375 294 | 104 120 126 |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 9 447 | 724 656 | 1,32 | 15,46 | 146 051 | 11 203 182 | |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −6 000 | 715 209 | −0,83 | 146,72 | −880 320 | 104 935 464 |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 000 | 721 209 | 0,84 | 15,46 | 92 760 | 11 149 891 | |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 497 | 715 209 | −0,35 | 147,68 | −368 757 | 105 622 065 |
2021-03-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 497 | 717 706 | 0,35 | 15,46 | 38 604 | 11 095 735 | |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 609 | 176 118 | −3,09 | ||||
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 195 | 181 727 | −4,82 | ||||
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 497 | 190 922 | −5,68 | ||||
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 063 | 202 419 | −1,01 | ||||
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −989 | 204 482 | −0,48 | ||||
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −5 609 | 715 209 | −0,78 | 166,82 | −935 693 | 119 311 165 |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 5 609 | 720 818 | 0,78 | 15,46 | 86 715 | 11 143 846 | |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −9 195 | 715 209 | −1,27 | 165,99 | −1 526 278 | 118 717 542 |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 9 195 | 724 404 | 1,29 | 15,46 | 142 155 | 11 199 286 | |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −11 497 | 715 209 | −1,58 | 165,10 | −1 898 155 | 118 081 006 |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 11 497 | 726 706 | 1,61 | 15,46 | 177 744 | 11 234 875 | |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 063 | 715 209 | −0,29 | 164,17 | −338 683 | 117 415 862 |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 063 | 717 272 | 0,29 | 15,46 | 31 894 | 11 089 025 | |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −989 | 715 209 | −0,14 | 163,09 | −161 296 | 116 643 436 |
2021-02-05 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 989 | 716 198 | 0,14 | 15,46 | 15 290 | 11 072 421 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 874 | 205 471 | −0,90 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 061 | 207 345 | −1,92 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 100 | 211 406 | −1,90 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 410 | 215 506 | −2,01 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 290 | 219 916 | −1,03 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 478 | 222 206 | −1,98 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 200 | 226 684 | −0,96 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 800 | 228 884 | −0,78 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 040 | 230 684 | −1,30 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 100 | 233 724 | −0,47 | ||||
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 874 | 715 209 | −0,26 | 176,46 | −330 686 | 126 205 780 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 874 | 717 083 | 0,26 | 15,46 | 28 972 | 11 086 103 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 061 | 715 209 | −0,56 | 175,66 | −713 355 | 125 633 613 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 061 | 719 270 | 0,57 | 15,46 | 62 783 | 11 119 914 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 100 | 715 209 | −0,57 | 174,46 | −715 286 | 124 775 362 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 100 | 719 309 | 0,57 | 15,46 | 63 386 | 11 120 517 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 410 | 715 209 | −0,61 | 173,39 | −764 650 | 124 010 089 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 410 | 719 619 | 0,62 | 15,46 | 68 179 | 11 125 310 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 290 | 715 209 | −0,32 | 172,60 | −395 254 | 123 445 073 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 290 | 717 499 | 0,32 | 15,46 | 35 403 | 11 092 535 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 478 | 715 209 | −0,62 | 171,38 | −767 440 | 122 572 518 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 478 | 719 687 | 0,63 | 15,46 | 69 230 | 11 126 361 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 200 | 715 209 | −0,31 | 170,22 | −374 484 | 121 742 876 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 200 | 717 409 | 0,31 | 15,46 | 34 012 | 11 091 143 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 800 | 715 209 | −0,25 | 169,28 | −304 704 | 121 070 580 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 800 | 717 009 | 0,25 | 15,46 | 27 828 | 11 084 959 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 040 | 715 209 | −0,42 | 168,32 | −511 693 | 120 383 979 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 040 | 718 249 | 0,43 | 15,46 | 46 998 | 11 104 130 | |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 100 | 715 209 | −0,15 | 167,39 | −184 129 | 119 718 835 |
2021-01-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 100 | 716 309 | 0,15 | 15,46 | 17 006 | 11 074 137 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −904 | 234 824 | −0,38 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 056 | 235 728 | −2,10 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 352 | 240 784 | −1,37 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 590 | 244 136 | −1,45 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 741 | 247 726 | −0,70 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 080 | 249 467 | −0,43 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −904 | 715 209 | −0,13 | 182,97 | −165 405 | 130 861 791 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 904 | 716 113 | 0,13 | 15,46 | 13 976 | 11 071 107 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −5 056 | 715 209 | −0,70 | 182,49 | −922 669 | 130 518 490 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 5 056 | 720 265 | 0,71 | 15,46 | 78 166 | 11 135 297 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 352 | 715 209 | −0,47 | 181,38 | −607 986 | 129 724 608 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 352 | 718 561 | 0,47 | 15,46 | 51 822 | 11 108 953 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 590 | 715 209 | −0,50 | 180,25 | −647 098 | 128 916 422 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 590 | 718 799 | 0,50 | 15,46 | 55 501 | 11 112 633 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 741 | 715 209 | −0,24 | 179,40 | −312 335 | 128 308 495 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 741 | 716 950 | 0,24 | 15,46 | 26 916 | 11 084 047 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 080 | 715 209 | −0,15 | 178,36 | −192 629 | 127 564 677 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 080 | 716 289 | 0,15 | 15,46 | 16 697 | 11 073 828 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −14 908 | 250 547 | −5,62 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 824 | 265 455 | −2,51 | ||||
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −14 908 | 715 209 | −2,04 | 179,17 | −2 671 066 | 128 143 997 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 14 908 | 730 117 | 2,08 | 15,46 | 230 478 | 11 287 609 | |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −6 824 | 715 209 | −0,95 | 180,00 | −1 228 320 | 128 737 620 |
2020-12-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 824 | 722 033 | 0,95 | 15,46 | 105 499 | 11 162 630 | |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 000 | 272 279 | −0,37 | ||||
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 120 | 273 279 | −0,41 | ||||
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 253 | 274 399 | −1,17 | ||||
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 844 | 277 652 | −1,71 | ||||
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 936 | 282 496 | −3,73 | ||||
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −100 | 293 432 | −0,03 | ||||
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 000 | 715 209 | −0,14 | 176,18 | −176 180 | 126 005 522 |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 000 | 716 209 | 0,14 | 15,46 | 15 460 | 11 072 591 | |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 120 | 715 209 | −0,16 | 177,28 | −198 554 | 126 792 252 |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 120 | 716 329 | 0,16 | 15,46 | 17 315 | 11 074 446 | |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 253 | 715 209 | −0,45 | 178,16 | −579 554 | 127 421 635 |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 3 253 | 718 462 | 0,45 | 15,46 | 50 291 | 11 107 423 | |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −4 844 | 715 209 | −0,67 | 179,14 | −867 754 | 128 122 540 |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 4 844 | 720 053 | 0,68 | 15,46 | 74 888 | 11 132 019 | |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −10 936 | 715 209 | −1,51 | 180,14 | −1 970 011 | 128 837 749 |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 10 936 | 726 145 | 1,53 | 15,46 | 169 071 | 11 226 202 | |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −100 | 715 209 | −0,01 | 180,91 | −18 091 | 129 388 460 |
2020-12-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 100 | 715 309 | 0,01 | 15,46 | 1 546 | 11 058 677 | |
2020-09-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 787 | 715 209 | −0,66 | 155,69 | −745 308 | 111 353 893 |
2020-09-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 564 | 719 996 | −1,31 | 155,69 | −1 489 059 | 112 099 201 |
2020-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −3 831 | 0 | −100,00 | ||||
2020-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −6 468 | 0 | −100,00 | ||||
2020-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 468 | 729 560 | 0,89 | 15,46 | 99 995 | 11 278 998 | |
2020-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 831 | 723 092 | 0,53 | 26,10 | 99 989 | 18 872 701 | |
2020-08-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −27 060 | 719 261 | −3,63 | 158,17 | −4 280 053 | 113 764 793 |
2020-08-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 68 747 | 68 747 | |||||
2020-08-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 636 | 636 | |||||
2020-08-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 27 982 | 746 321 | 3,90 | ||||
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 619 | 0 | −100,00 | ||||
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 354 | 4 619 | −33,76 | ||||
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 616 | 6 973 | −62,49 | ||||
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 486 | 18 589 | −33,79 | ||||
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −400 | 28 075 | −1,40 | ||||
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 619 | 718 339 | −0,64 | 154,76 | −714 836 | 111 170 144 |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 619 | 722 958 | 0,64 | 12,00 | 55 428 | 8 675 496 | |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 354 | 718 339 | −0,33 | 155,96 | −367 130 | 112 032 150 |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 354 | 720 693 | 0,33 | 12,00 | 28 248 | 8 648 316 | |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −11 616 | 718 339 | −1,59 | 156,89 | −1 822 434 | 112 700 206 |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 11 616 | 729 955 | 1,62 | 12,00 | 139 392 | 8 759 460 | |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 486 | 718 339 | −1,30 | 157,63 | −1 495 278 | 113 231 777 |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 486 | 727 825 | 1,32 | 12,00 | 113 832 | 8 733 900 | |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −400 | 718 339 | −0,06 | 158,96 | −63 584 | 114 187 167 |
2020-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 400 | 718 739 | 0,06 | 12,00 | 4 800 | 8 624 868 | |
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
M - Exercise | −1 596 | 0 | −100,00 | ||||
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
S - Sale | −1 596 | 2 550 | −38,49 | 85,01 | −135 676 | 216 776 | |
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
M - Exercise | 1 596 | 4 146 | 62,59 | 40,37 | 64 431 | 167 374 | |
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
S - Sale | −9 750 | 2 550 | −79,27 | 85,01 | −828 848 | 216 776 | |
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
M - Exercise | −17 500 | 0 | −100,00 | ||||
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 904 | 1 596 | −78,72 | ||||
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
S - Sale | −23 404 | 12 300 | −65,55 | 85,55 | −2 002 212 | 1 052 265 | |
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
M - Exercise | 17 500 | 35 704 | 96,13 | 21,00 | 367 500 | 749 784 | |
2020-08-11 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
M - Exercise | 5 904 | 18 204 | 48,00 | 40,37 | 238 344 | 734 895 | |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −400 | 28 475 | −1,39 | ||||
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −400 | 28 475 | −1,39 | ||||
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 277 | 28 875 | −12,90 | ||||
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 321 | 33 152 | −32,99 | ||||
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 274 | 49 473 | −11,25 | ||||
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −800 | 56 147 | −1,40 | ||||
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −400 | 718 339 | −0,06 | 172,55 | −69 020 | 123 949 394 |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 400 | 718 739 | 0,06 | 12,00 | 4 800 | 8 624 868 | |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 400 | 718 739 | 0,06 | 12,00 | 4 800 | 8 624 868 | |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 277 | 718 339 | −0,59 | 174,07 | −744 497 | 125 041 270 |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 277 | 722 616 | 0,60 | 12,00 | 51 324 | 8 671 392 | |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −16 321 | 718 339 | −2,22 | 174,99 | −2 856 012 | 125 702 142 |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 16 321 | 734 660 | 2,27 | 12,00 | 195 852 | 8 815 920 | |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 274 | 718 339 | −0,87 | 175,69 | −1 102 279 | 126 204 979 |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 274 | 724 613 | 0,87 | 12,00 | 75 288 | 8 695 356 | |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −400 | 718 339 | −0,06 | 176,94 | −70 776 | 127 102 903 |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −800 | 718 339 | −0,11 | 177,78 | −142 224 | 127 706 307 |
2020-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 800 | 719 139 | 0,11 | 12,00 | 9 600 | 8 629 668 | |
2020-06-30 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
A - Award | 4 250 | 4 250 | |||||
2020-06-30 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
A - Award | 2 550 | 12 300 | 26,15 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 700 | 56 947 | −4,53 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 300 | 59 647 | −3,71 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 500 | 61 947 | −5,35 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 800 | 65 447 | −4,10 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 635 | 68 247 | −6,36 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 937 | 72 882 | −7,53 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 600 | 78 819 | −7,73 | ||||
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 700 | 718 339 | −0,37 | 145,03 | −391 581 | 104 180 705 |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 700 | 721 039 | 0,38 | 12,00 | 32 400 | 8 652 468 | |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 300 | 718 339 | −0,32 | 146,07 | −335 961 | 104 927 778 |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 300 | 720 639 | 0,32 | 12,00 | 27 600 | 8 647 668 | |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 500 | 718 339 | −0,48 | 147,00 | −514 500 | 105 595 833 |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 500 | 721 839 | 0,49 | 12,00 | 42 000 | 8 662 068 | |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 800 | 718 339 | −0,39 | 148,12 | −414 736 | 106 400 373 |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 800 | 721 139 | 0,39 | 12,00 | 33 600 | 8 653 668 | |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 635 | 718 339 | −0,64 | 148,85 | −689 920 | 106 924 760 |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 635 | 722 974 | 0,65 | 12,00 | 55 620 | 8 675 688 | |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 937 | 718 339 | −0,82 | 150,23 | −891 916 | 107 916 068 |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 937 | 724 276 | 0,83 | 12,00 | 71 244 | 8 691 312 | |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 600 | 718 339 | −0,91 | 151,09 | −997 194 | 108 533 840 |
2020-06-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 600 | 724 939 | 0,92 | 12,00 | 79 200 | 8 699 268 | |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 100 | 85 419 | −1,27 | ||||
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 549 | 86 519 | −3,94 | ||||
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 355 | 90 068 | −5,61 | ||||
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 204 | 95 423 | −7,92 | ||||
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 264 | 103 627 | −9,01 | ||||
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 100 | 718 339 | −0,15 | 163,50 | −179 850 | 117 448 426 |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 100 | 719 439 | 0,15 | 12,00 | 13 200 | 8 633 268 | |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 549 | 718 339 | −0,49 | 162,68 | −577 351 | 116 859 389 |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 549 | 721 888 | 0,49 | 12,00 | 42 588 | 8 662 656 | |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 355 | 718 339 | −0,74 | 161,74 | −866 118 | 116 184 150 |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 355 | 723 694 | 0,75 | 12,00 | 64 260 | 8 684 328 | |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 204 | 718 339 | −1,13 | 160,72 | −1 318 547 | 115 451 444 |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 204 | 726 543 | 1,14 | 12,00 | 98 448 | 8 718 516 | |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 264 | 718 339 | −1,41 | 160,02 | −1 642 445 | 114 948 607 |
2020-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 264 | 728 603 | 1,43 | 12,00 | 123 168 | 8 743 236 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −2 400 | 718 339 | −0,33 | 166,55 | −399 720 | 119 639 360 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −12 656 | 720 739 | −1,73 | 165,77 | −2 097 985 | 119 476 904 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −6 400 | 733 395 | −0,87 | 164,55 | −1 053 120 | 120 680 147 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −3 946 | 739 795 | −0,53 | 163,77 | −646 236 | 121 156 227 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −4 297 | 743 741 | −0,57 | 167,67 | −720 478 | 124 703 053 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −6 700 | 748 038 | −0,89 | 167,06 | −1 119 302 | 124 967 228 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −6 432 | 754 738 | −0,85 | 165,44 | −1 064 110 | 124 863 855 | |
2020-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −7 169 | 761 170 | −0,93 | 164,80 | −1 181 451 | 125 440 816 | |
2020-04-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
D - Sale to Issuer | X | −3 023 | 768 339 | −0,39 | 139,92 | −422 969 | 107 503 611 |
2020-04-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 4 729 | 771 362 | 0,62 | ||||
2020-04-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 7 849 | 766 633 | 1,03 | ||||
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −21 082 | 113 891 | −15,62 | ||||
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −400 | 134 973 | −0,30 | ||||
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 672 | 135 373 | −1,94 | ||||
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 318 | 138 045 | −3,03 | ||||
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −21 082 | 758 784 | −2,70 | 120,00 | −2 529 840 | 91 054 080 |
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 21 082 | 779 866 | 2,78 | 12,00 | 252 984 | 9 358 392 | |
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −400 | 758 784 | −0,05 | 122,52 | −49 008 | 92 966 216 |
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 400 | 759 184 | 0,05 | 12,00 | 4 800 | 9 110 208 | |
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 672 | 758 784 | −0,35 | 120,90 | −323 045 | 91 736 986 |
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 672 | 761 456 | 0,35 | 12,00 | 32 064 | 9 137 472 | |
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 318 | 758 784 | −0,57 | 119,25 | −514 922 | 90 484 992 |
2020-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 318 | 763 102 | 0,57 | 12,00 | 51 816 | 9 157 224 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −200 | 142 363 | −0,14 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 549 | 142 563 | −1,07 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −953 | 144 112 | −0,66 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 386 | 145 065 | −1,62 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 661 | 147 451 | −5,55 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 797 | 156 112 | −5,91 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 926 | 165 909 | −2,31 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −900 | 169 835 | −0,53 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −100 | 170 735 | −0,06 | ||||
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −200 | 758 784 | −0,03 | 105,29 | −21 058 | 79 892 367 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 200 | 758 984 | 0,03 | 12,00 | 2 400 | 9 107 808 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 549 | 758 784 | −0,20 | 106,87 | −165 542 | 81 091 246 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 549 | 760 333 | 0,20 | 12,00 | 18 588 | 9 123 996 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −953 | 758 784 | −0,13 | 107,53 | −102 476 | 81 592 044 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 953 | 759 737 | 0,13 | 12,00 | 11 436 | 9 116 844 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 386 | 758 784 | −0,31 | 108,68 | −259 310 | 82 464 645 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 386 | 761 170 | 0,31 | 12,00 | 28 632 | 9 134 040 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 661 | 758 784 | −1,13 | 109,75 | −950 545 | 83 276 544 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 661 | 767 445 | 1,14 | 12,00 | 103 932 | 9 209 340 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 797 | 758 784 | −1,27 | 110,79 | −1 085 410 | 84 065 679 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 797 | 768 581 | 1,29 | 12,00 | 117 564 | 9 222 972 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 926 | 758 784 | −0,51 | 111,47 | −437 631 | 84 581 652 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 926 | 762 710 | 0,52 | 12,00 | 47 112 | 9 152 520 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −900 | 758 784 | −0,12 | 112,53 | −101 277 | 85 385 964 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 900 | 759 684 | 0,12 | 12,00 | 10 800 | 9 116 208 | |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −100 | 758 784 | −0,01 | 113,29 | −11 329 | 85 962 639 |
2020-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 100 | 758 884 | 0,01 | 12,00 | 1 200 | 9 106 608 | |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 286 | 170 835 | −4,63 | ||||
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 939 | 179 121 | −5,26 | ||||
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 002 | 189 060 | −2,58 | ||||
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 245 | 194 062 | −2,63 | ||||
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 286 | 758 784 | −1,08 | 113,39 | −939 550 | 86 038 518 |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 286 | 767 070 | 1,09 | 12,00 | 99 432 | 9 204 840 | |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 939 | 758 784 | −1,29 | 114,32 | −1 136 226 | 86 744 187 |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 939 | 768 723 | 1,31 | 12,00 | 119 268 | 9 224 676 | |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 002 | 758 784 | −0,65 | 115,38 | −577 131 | 87 548 498 |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 002 | 763 786 | 0,66 | 12,00 | 60 024 | 9 165 432 | |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 245 | 758 784 | −0,69 | 116,34 | −610 203 | 88 276 931 |
2020-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 245 | 764 029 | 0,69 | 12,00 | 62 940 | 9 168 348 | |
2020-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −27 153 | 199 307 | −11,99 | ||||
2020-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 319 | 226 460 | −0,58 | ||||
2020-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −27 153 | 758 784 | −3,45 | 111,28 | −3 021 586 | 84 437 484 |
2020-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 27 153 | 785 937 | 3,58 | 12,00 | 325 836 | 9 431 244 | |
2020-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 319 | 758 784 | −0,17 | 112,09 | −147 847 | 85 052 099 |
2020-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 319 | 760 103 | 0,17 | 12,00 | 15 828 | 9 121 236 | |
2019-12-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 100 | 758 784 | 0,41 | ||||
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −500 | 227 779 | −0,22 | ||||
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 800 | 228 279 | −0,78 | ||||
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 111 | 230 079 | −0,91 | ||||
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 734 | 232 190 | −2,82 | ||||
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −17 327 | 238 924 | −6,76 | ||||
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −500 | 755 684 | −0,07 | 117,76 | −58 880 | 88 989 348 |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 500 | 756 184 | 0,07 | 12,00 | 6 000 | 9 074 208 | |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 800 | 755 684 | −0,24 | 116,98 | −210 564 | 88 399 914 |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 800 | 757 484 | 0,24 | 12,00 | 21 600 | 9 089 808 | |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 111 | 755 684 | −0,28 | 115,53 | −243 884 | 87 304 173 |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 111 | 757 795 | 0,28 | 12,00 | 25 332 | 9 093 540 | |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 734 | 755 684 | −0,88 | 114,59 | −771 649 | 86 593 830 |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 734 | 762 418 | 0,89 | 12,00 | 80 808 | 9 149 016 | |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −17 327 | 755 684 | −2,24 | 114,08 | −1 976 664 | 86 208 431 |
2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17 327 | 773 011 | 2,29 | 12,00 | 207 924 | 9 276 132 | |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 799 | 256 251 | −7,51 | ||||
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 968 | 277 050 | −1,41 | ||||
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 120 | 281 018 | −0,75 | ||||
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 585 | 283 138 | −0,56 | ||||
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −20 799 | 755 684 | −2,68 | 108,08 | −2 247 956 | 81 674 327 |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 20 799 | 776 483 | 2,75 | 12,00 | 249 588 | 9 317 796 | |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 968 | 755 684 | −0,52 | 107,32 | −425 846 | 81 100 007 |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 968 | 759 652 | 0,53 | 12,00 | 47 616 | 9 115 824 | |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 120 | 755 684 | −0,28 | 105,93 | −224 572 | 80 049 606 |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 120 | 757 804 | 0,28 | 12,00 | 25 440 | 9 093 648 | |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 585 | 755 684 | −0,21 | 104,38 | −165 442 | 78 878 296 |
2019-11-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 585 | 757 269 | 0,21 | 12,00 | 19 020 | 9 087 228 | |
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −22 500 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 350 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 363 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 363 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 363 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 363 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 363 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
U - Other | −31 714 | 0 | −100,00 | 18,00 | −570 852 | ||
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −14 420 | 284 723 | −4,82 | ||||
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −13 352 | 299 143 | −4,27 | ||||
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −700 | 312 495 | −0,22 | ||||
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −14 420 | 755 684 | −1,87 | 82,01 | −1 182 584 | 61 973 645 |
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 14 420 | 770 104 | 1,91 | 12,00 | 173 040 | 9 241 248 | |
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −13 352 | 755 684 | −1,74 | 82,89 | −1 106 747 | 62 638 647 |
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 13 352 | 769 036 | 1,77 | 12,00 | 160 224 | 9 228 432 | |
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −700 | 755 684 | −0,09 | 83,90 | −58 730 | 63 401 888 |
2019-10-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 700 | 756 384 | 0,09 | 12,00 | 8 400 | 9 076 608 | |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −18 690 | 313 195 | −5,63 | ||||
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 257 | 331 885 | −2,71 | ||||
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −521 | 341 142 | −0,15 | ||||
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 | 341 663 | 0,00 | ||||
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −18 690 | 755 684 | −2,41 | 68,00 | −1 270 920 | 51 386 512 |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 18 690 | 774 374 | 2,47 | 12,00 | 224 280 | 9 292 488 | |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 257 | 755 684 | −1,21 | 68,91 | −637 900 | 52 074 184 |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 257 | 764 941 | 1,22 | 12,00 | 111 084 | 9 179 292 | |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −521 | 755 684 | −0,07 | 69,92 | −36 428 | 52 837 425 |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 521 | 756 205 | 0,07 | 12,00 | 6 252 | 9 074 460 | |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 | 755 684 | 0,00 | 70,80 | −283 | 53 502 427 |
2019-09-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 | 755 688 | 0,00 | 12,00 | 48 | 9 068 256 | |
2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 693 | 755 684 | −1,27 | 70,80 | −686 257 | 53 501 823 |
2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 112 762 | 112 762 | |||||
2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 1 333 | 1 333 | |||||
2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 48 034 | 765 377 | 6,70 | ||||
2019-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −28 951 | 717 343 | −3,88 | 73,21 | −2 119 636 | 52 519 981 |
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 300 | 0 | −100,00 | ||||
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 951 | 2 300 | −77,56 | ||||
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 898 | 10 251 | −49,12 | ||||
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 300 | 746 294 | −0,31 | 75,25 | −173 075 | 56 158 624 |
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 300 | 748 594 | 0,31 | 12,16 | 27 968 | 9 102 903 | |
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 951 | 746 294 | −1,05 | 76,43 | −607 695 | 57 039 250 |
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 951 | 754 245 | 1,07 | 12,16 | 96 684 | 9 171 619 | |
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 898 | 746 294 | −1,31 | 76,89 | −761 057 | 57 382 546 |
2019-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 898 | 756 192 | 1,33 | 12,16 | 120 360 | 9 195 295 | |
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −14 717 | 20 149 | −42,21 | ||||
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 231 | 34 866 | −13,05 | ||||
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −200 | 40 097 | −0,50 | ||||
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −14 717 | 746 294 | −1,93 | 66,71 | −981 771 | 49 785 273 |
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 14 717 | 761 011 | 1,97 | 12,16 | 178 959 | 9 253 894 | |
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 231 | 746 294 | −0,70 | 67,33 | −352 203 | 50 247 975 |
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 231 | 751 525 | 0,70 | 12,16 | 63 609 | 9 138 544 | |
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −200 | 746 294 | −0,03 | 68,45 | −13 690 | 51 083 824 |
2019-07-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 200 | 746 494 | 0,03 | 12,16 | 2 432 | 9 077 367 | |
2019-06-13 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
A - Award | 5 000 | 5 000 | |||||
2019-06-13 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
A - Award | 3 000 | 9 750 | 44,44 | ||||
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 746 | 40 297 | −12,48 | ||||
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 950 | 46 043 | −19,21 | ||||
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 552 | 56 993 | −4,29 | ||||
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −900 | 59 545 | −1,49 | ||||
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −2 875 | 746 294 | −0,38 | ||||
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 746 | 749 169 | −0,76 | 68,21 | −391 935 | 51 100 817 |
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 746 | 754 915 | 0,77 | 12,16 | 69 871 | 9 179 766 | |
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 950 | 749 169 | −1,44 | 69,13 | −756 974 | 51 790 053 |
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 950 | 760 119 | 1,46 | 12,16 | 133 152 | 9 243 047 | |
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 552 | 749 169 | −0,34 | 69,90 | −178 385 | 52 366 913 |
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 552 | 751 721 | 0,34 | 12,16 | 31 032 | 9 140 927 | |
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −900 | 749 169 | −0,12 | 70,98 | −63 882 | 53 176 016 |
2019-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 900 | 750 069 | 0,12 | 12,16 | 10 944 | 9 120 839 | |
2019-05-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 22 500 | 22 500 | |||||
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 930 | 60 445 | −3,09 | ||||
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 894 | 62 375 | −4,43 | ||||
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 930 | 749 169 | −0,26 | 66,93 | −129 175 | 50 141 881 |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 930 | 751 099 | 0,26 | 12,16 | 23 469 | 9 133 364 | |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 894 | 749 169 | −0,38 | 67,77 | −196 126 | 50 771 183 |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 894 | 752 063 | 0,39 | 12,16 | 35 191 | 9 145 086 | |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 593 | 65 269 | −2,38 | ||||
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −13 431 | 66 862 | −16,73 | ||||
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −300 | 80 293 | −0,37 | ||||
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 593 | 749 169 | −0,21 | 67,41 | −107 384 | 50 501 482 |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 593 | 750 762 | 0,21 | 12,16 | 19 371 | 9 129 266 | |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −13 431 | 749 169 | −1,76 | 68,35 | −918 009 | 51 205 701 |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 13 431 | 762 600 | 1,79 | 12,16 | 163 321 | 9 273 216 | |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −300 | 749 169 | −0,04 | 68,91 | −20 673 | 51 625 236 |
2019-05-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 300 | 749 469 | 0,04 | 12,16 | 3 648 | 9 113 543 | |
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 800 | 80 593 | −3,36 | ||||
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 541 | 83 393 | −9,29 | ||||
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 807 | 91 934 | −8,74 | ||||
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 800 | 749 169 | −0,37 | 78,00 | −218 400 | 58 435 182 |
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 800 | 751 969 | 0,37 | 12,16 | 34 048 | 9 143 943 | |
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 541 | 749 169 | −1,13 | 79,05 | −675 166 | 59 221 809 |
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 541 | 757 710 | 1,14 | 12,16 | 103 859 | 9 213 754 | |
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 807 | 749 169 | −1,16 | 79,77 | −702 534 | 59 761 211 |
2019-04-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 807 | 757 976 | 1,18 | 12,16 | 107 093 | 9 216 988 | |
2019-03-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −8 223 | 0 | −100,00 | ||||
2019-03-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −8 333 | 0 | −100,00 | ||||
2019-03-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 333 | 749 169 | 1,12 | 12,00 | 99 996 | 8 990 028 | |
2019-03-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 223 | 740 836 | 1,12 | 12,16 | 99 992 | 9 008 566 | |
2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 502 | 100 741 | −6,93 | ||||
2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −12 646 | 108 243 | −10,46 | ||||
2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 502 | 732 613 | −1,01 | 68,86 | −516 588 | 50 447 731 |
2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 502 | 740 115 | 1,02 | 12,16 | 91 224 | 8 999 798 | |
2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −12 646 | 732 613 | −1,70 | 69,39 | −877 506 | 50 836 016 |
2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 12 646 | 745 259 | 1,73 | 12,16 | 153 775 | 9 062 349 | |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 077 | 120 889 | −6,26 | ||||
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 100 | 128 966 | −5,22 | ||||
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 571 | 136 066 | −2,56 | ||||
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 400 | 139 637 | −0,99 | ||||
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 077 | 732 613 | −1,09 | 64,49 | −520 886 | 47 246 212 |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 077 | 740 690 | 1,10 | 12,16 | 98 216 | 9 006 790 | |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 100 | 732 613 | −0,96 | 65,00 | −461 500 | 47 619 845 |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 100 | 739 713 | 0,97 | 12,16 | 86 336 | 8 994 910 | |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 571 | 732 613 | −0,49 | 66,32 | −236 829 | 48 586 894 |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 571 | 736 184 | 0,49 | 12,16 | 43 423 | 8 951 997 | |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 400 | 732 613 | −0,19 | 67,08 | −93 912 | 49 143 680 |
2019-02-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 400 | 734 013 | 0,19 | 12,16 | 17 024 | 8 925 598 | |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 000 | 141 037 | −2,08 | ||||
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 100 | 144 037 | −4,70 | ||||
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 600 | 151 137 | −2,95 | ||||
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 448 | 155 737 | −3,38 | ||||
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 000 | 732 613 | −0,41 | 64,21 | −192 630 | 47 041 081 |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 000 | 735 613 | 0,41 | 12,16 | 36 480 | 8 945 054 | |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 100 | 732 613 | −0,96 | 65,17 | −462 707 | 47 744 389 |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 100 | 739 713 | 0,97 | 12,16 | 86 336 | 8 994 910 | |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 600 | 732 613 | −0,62 | 66,05 | −303 830 | 48 389 089 |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 600 | 737 213 | 0,63 | 12,16 | 55 936 | 8 964 510 | |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 448 | 732 613 | −0,74 | 67,01 | −365 070 | 49 092 397 |
2019-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 448 | 738 061 | 0,74 | 12,16 | 66 248 | 8 974 822 | |
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −700 | 161 185 | −0,43 | ||||
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −13 148 | 161 885 | −7,51 | ||||
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 300 | 175 033 | −3,47 | ||||
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −700 | 732 613 | −0,10 | 60,78 | −42 546 | 44 528 218 |
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 700 | 733 313 | 0,10 | 12,16 | 8 512 | 8 917 086 | |
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −13 148 | 732 613 | −1,76 | 59,96 | −788 354 | 43 927 475 |
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 13 148 | 745 761 | 1,79 | 12,16 | 159 880 | 9 068 454 | |
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 300 | 732 613 | −0,85 | 59,15 | −372 645 | 43 334 059 |
2018-12-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 300 | 738 913 | 0,86 | 12,16 | 76 608 | 8 985 182 | |
2018-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −13 478 | 181 333 | −6,92 | ||||
2018-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 670 | 194 811 | −3,31 | ||||
2018-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −13 478 | 732 613 | −1,81 | 61,29 | −826 067 | 44 901 851 |
2018-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 13 478 | 746 091 | 1,84 | 12,16 | 163 892 | 9 072 467 | |
2018-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 670 | 732 613 | −0,90 | 62,04 | −413 807 | 45 451 311 |
2018-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 670 | 739 283 | 0,91 | 12,16 | 81 107 | 8 989 681 | |
2018-10-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 211 | 201 481 | −2,99 | ||||
2018-10-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −13 937 | 207 692 | −6,29 | ||||
2018-10-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 211 | 732 613 | −0,84 | 76,96 | −477 999 | 56 381 896 |
2018-10-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 211 | 738 824 | 0,85 | 12,16 | 75 526 | 8 984 100 | |
2018-10-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −13 937 | 732 613 | −1,87 | 77,58 | −1 081 232 | 56 836 117 |
2018-10-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 13 937 | 746 550 | 1,90 | 12,16 | 169 474 | 9 078 048 | |
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 390 | 221 629 | −0,62 | ||||
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 827 | 223 019 | −3,81 | ||||
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 931 | 231 846 | −4,11 | ||||
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 390 | 732 613 | −0,19 | 78,00 | −108 420 | 57 143 814 |
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 390 | 734 003 | 0,19 | 12,16 | 16 902 | 8 925 476 | |
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 827 | 732 613 | −1,19 | 77,20 | −681 444 | 56 557 724 |
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 827 | 741 440 | 1,20 | 12,16 | 107 336 | 9 015 910 | |
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 931 | 732 613 | −1,34 | 76,36 | −758 331 | 55 942 329 |
2018-09-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 931 | 742 544 | 1,36 | 12,16 | 120 761 | 9 029 335 | |
2018-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 226 683 | 226 683 | |||||
2018-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 1 301 | 1 301 | |||||
2018-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 95 981 | 732 613 | 15,08 | ||||
2018-08-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −25 514 | 636 632 | −3,85 | 74,23 | −1 893 950 | 47 258 339 |
2018-08-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −25 000 | 662 146 | −3,64 | 74,95 | −1 873 750 | 49 627 843 | |
2018-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 120 | 0 | −100,00 | ||||
2018-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 711 | 2 120 | −88,74 | ||||
2018-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 120 | 687 146 | −0,31 | 73,16 | −155 099 | 50 271 601 |
2018-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 120 | 689 266 | 0,31 | 11,09 | 23 511 | 7 643 960 | |
2018-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −16 711 | 687 146 | −2,37 | 72,65 | −1 214 054 | 49 921 157 |
2018-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 16 711 | 703 857 | 2,43 | 11,09 | 185 325 | 7 805 774 | |
2018-07-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 622 | 18 831 | −16,13 | ||||
2018-07-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −15 210 | 22 453 | −40,38 | ||||
2018-07-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 622 | 687 146 | −0,52 | 69,67 | −252 345 | 47 873 462 |
2018-07-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 622 | 690 768 | 0,53 | 11,09 | 40 168 | 7 660 617 | |
2018-07-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −15 210 | 687 146 | −2,17 | 68,93 | −1 048 425 | 47 364 974 |
2018-07-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 15 210 | 702 356 | 2,21 | 11,09 | 168 679 | 7 789 128 | |
2018-06-20 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
A - Award | 5 000 | 5 000 | |||||
2018-06-20 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
A - Award | 3 000 | 6 750 | 80,00 | ||||
2018-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −18 132 | 37 663 | −32,50 | ||||
2018-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −700 | 55 795 | −1,24 | ||||
2018-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −18 132 | 687 146 | −2,57 | 65,10 | −1 180 393 | 44 733 205 |
2018-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 18 132 | 705 278 | 2,64 | 11,09 | 201 084 | 7 821 533 | |
2018-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −700 | 687 146 | −0,10 | 65,64 | −45 948 | 45 104 263 |
2018-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 700 | 687 846 | 0,10 | 11,09 | 7 763 | 7 628 212 | |
2018-05-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 740 | 56 495 | −10,66 | ||||
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 776 | 63 235 | −10,95 | ||||
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 316 | 71 011 | −5,73 | ||||
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 740 | 687 146 | −0,97 | 54,17 | −365 106 | 37 222 699 |
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 740 | 693 886 | 0,98 | 11,09 | 74 747 | 7 695 196 | |
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 776 | 687 146 | −1,12 | 55,22 | −429 391 | 37 944 202 |
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 776 | 694 922 | 1,13 | 11,09 | 86 236 | 7 706 685 | |
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 316 | 687 146 | −0,62 | 55,75 | −240 617 | 38 308 390 |
2018-05-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 316 | 691 462 | 0,63 | 11,09 | 47 864 | 7 668 314 | |
2018-04-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −18 832 | 75 327 | −20,00 | ||||
2018-04-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −18 832 | 687 146 | −2,67 | 50,52 | −951 393 | 34 714 616 |
2018-04-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 18 832 | 705 978 | 2,74 | 11,09 | 208 847 | 7 829 296 | |
2018-03-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-qualified Stock Option (Right to buy) |
A - Award | 37 280 | 37 280 | |||||
2018-03-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −14 068 | 94 159 | −13,00 | ||||
2018-03-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 764 | 108 227 | −4,22 | ||||
2018-03-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −14 068 | 687 146 | −2,01 | 57,17 | −804 268 | 39 284 137 |
2018-03-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 14 068 | 701 214 | 2,05 | 11,09 | 156 014 | 7 776 463 | |
2018-03-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 764 | 687 146 | −0,69 | 57,76 | −275 169 | 39 689 553 |
2018-03-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 764 | 691 910 | 0,69 | 11,09 | 52 833 | 7 673 282 | |
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 400 | 112 991 | −8,43 | ||||
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 632 | 123 391 | −5,82 | ||||
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −800 | 131 023 | −0,61 | ||||
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 400 | 687 146 | −1,49 | 49,23 | −511 992 | 33 828 198 |
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 400 | 697 546 | 1,51 | 11,09 | 115 336 | 7 735 785 | |
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 632 | 687 146 | −1,10 | 50,32 | −384 042 | 34 577 187 |
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 632 | 694 778 | 1,11 | 11,09 | 84 639 | 7 705 088 | |
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −800 | 687 146 | −0,12 | 50,98 | −40 784 | 35 030 703 |
2018-02-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 800 | 687 946 | 0,12 | 11,09 | 8 872 | 7 629 321 | |
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −700 | 131 823 | −0,53 | ||||
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 562 | 132 523 | −5,40 | ||||
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 570 | 140 085 | −7,02 | ||||
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −700 | 687 146 | −0,10 | 52,95 | −37 065 | 36 384 381 |
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 700 | 687 846 | 0,10 | 11,09 | 7 763 | 7 628 212 | |
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 562 | 687 146 | −1,09 | 51,94 | −392 770 | 35 690 363 |
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 562 | 694 708 | 1,10 | 11,09 | 83 863 | 7 704 312 | |
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 570 | 687 146 | −1,51 | 51,47 | −544 038 | 35 367 405 |
2018-01-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 570 | 697 716 | 1,54 | 11,09 | 117 221 | 7 737 670 | |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 800 | 150 655 | −1,18 | ||||
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 300 | 152 455 | −1,49 | ||||
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 787 | 154 755 | −7,08 | ||||
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 945 | 166 542 | −1,74 | ||||
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 800 | 687 146 | −0,26 | 53,62 | −96 516 | 36 844 769 |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 800 | 688 946 | 0,26 | 11,09 | 19 962 | 7 640 411 | |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 300 | 687 146 | −0,33 | 54,67 | −125 741 | 37 566 272 |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 300 | 689 446 | 0,33 | 11,09 | 25 507 | 7 645 956 | |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −11 787 | 687 146 | −1,69 | 55,57 | −655 004 | 38 184 703 |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 11 787 | 698 933 | 1,72 | 11,09 | 130 718 | 7 751 167 | |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 945 | 687 146 | −0,43 | 56,39 | −166 069 | 38 748 163 |
2017-12-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 945 | 690 091 | 0,43 | 11,09 | 32 660 | 7 653 109 | |
2017-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −17 109 | 169 487 | −9,17 | ||||
2017-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 723 | 186 596 | −0,91 | ||||
2017-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −17 109 | 687 146 | −2,43 | 57,95 | −991 467 | 39 820 111 |
2017-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17 109 | 704 255 | 2,49 | 11,09 | 189 739 | 7 810 188 | |
2017-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 723 | 687 146 | −0,25 | 58,46 | −100 727 | 40 170 555 |
2017-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 723 | 688 869 | 0,25 | 11,09 | 19 108 | 7 639 557 | |
2017-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −9 090 | 0 | −100,00 | ||||
2017-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −9 090 | 0 | −100,00 | ||||
2017-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −9 090 | 0 | −100,00 | ||||
2017-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 9 090 | 31 714 | 40,18 | 0,99 | 8 999 | 31 397 | |
2017-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 9 090 | 22 624 | 67,16 | 1,65 | 14 998 | 37 330 | |
2017-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 9 090 | 13 534 | 204,55 | 1,26 | 11 499 | 17 121 | |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 797 | 188 319 | −0,95 | ||||
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −837 | 190 116 | −0,44 | ||||
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 400 | 190 953 | −0,73 | ||||
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 899 | 192 353 | −3,46 | ||||
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 699 | 199 252 | −3,25 | ||||
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 200 | 205 951 | −0,58 | ||||
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 797 | 687 146 | −0,26 | 57,79 | −103 849 | 39 710 167 |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 797 | 688 943 | 0,26 | 11,09 | 19 929 | 7 640 378 | |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −837 | 687 146 | −0,12 | 58,86 | −49 266 | 40 445 414 |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 837 | 687 983 | 0,12 | 11,09 | 9 282 | 7 629 731 | |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 400 | 687 146 | −0,20 | 60,37 | −84 518 | 41 483 004 |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 400 | 688 546 | 0,20 | 11,09 | 15 526 | 7 635 975 | |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 899 | 687 146 | −0,99 | 61,33 | −423 116 | 42 142 664 |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 899 | 694 045 | 1,00 | 11,09 | 76 510 | 7 696 959 | |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 699 | 687 146 | −0,97 | 62,08 | −415 874 | 42 658 024 |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 699 | 693 845 | 0,97 | 11,09 | 74 292 | 7 694 741 | |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 200 | 687 146 | −0,17 | 63,01 | −75 612 | 43 297 069 |
2017-10-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 200 | 688 346 | 0,17 | 11,09 | 13 308 | 7 633 757 | |
2017-09-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −9 017 | 0 | −100,00 | ||||
2017-09-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 017 | 687 146 | 1,33 | 11,09 | 99 999 | 7 620 449 | |
2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −17 117 | 207 151 | −7,63 | ||||
2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 715 | 224 268 | −0,76 | ||||
2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −17 117 | 678 129 | −2,46 | 53,42 | −914 390 | 36 225 651 |
2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17 117 | 695 246 | 2,52 | 11,09 | 189 828 | 7 710 278 | |
2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 715 | 678 129 | −0,25 | 54,15 | −92 867 | 36 720 685 |
2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 715 | 679 844 | 0,25 | 11,09 | 19 019 | 7 539 470 | |
2017-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −25 506 | 678 129 | −3,62 | 47,89 | −1 221 597 | 32 478 649 |
2017-08-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 165 844 | 165 844 | |||||
2017-08-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 156 | 2 156 | |||||
2017-08-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 67 200 | 703 635 | 10,56 | ||||
2017-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 413 | 0 | −100,00 | ||||
2017-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 413 | 636 435 | −1,61 | 48,91 | −509 300 | 31 128 036 |
2017-08-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 413 | 646 848 | 1,64 | 10,29 | 107 150 | 6 656 066 | |
2017-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 194 | 10 413 | −44,04 | ||||
2017-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 229 | 18 607 | −10,70 | ||||
2017-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 194 | 636 435 | −1,27 | 51,86 | −424 941 | 33 005 519 |
2017-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 194 | 644 629 | 1,29 | 10,29 | 84 316 | 6 633 232 | |
2017-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 229 | 636 435 | −0,35 | 52,43 | −116 866 | 33 368 287 |
2017-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 229 | 638 664 | 0,35 | 10,29 | 22 936 | 6 571 853 | |
2017-06-22 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Employee Stock Option (Right to Buy) |
A - Award | 3 750 | 3 750 | |||||
2017-06-22 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
A - Award | 1 875 | 3 750 | 100,00 | ||||
2017-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 760 | 20 836 | −31,90 | ||||
2017-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −663 | 30 596 | −2,12 | ||||
2017-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 760 | 636 435 | −1,51 | 65,17 | −636 059 | 41 476 469 |
2017-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 760 | 646 195 | 1,53 | 10,29 | 100 430 | 6 649 347 | |
2017-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −663 | 636 435 | −0,10 | 65,82 | −43 639 | 41 890 152 |
2017-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 663 | 637 098 | 0,10 | 10,29 | 6 822 | 6 555 738 | |
2017-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 330 | 31 259 | −22,99 | ||||
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −993 | 40 589 | −2,39 | ||||
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −100 | 41 582 | −0,24 | ||||
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 039 | 0 | −100,00 | ||||
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 039 | 636 435 | −0,63 | 61,47 | −248 277 | 39 121 659 |
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 039 | 640 474 | 0,63 | 10,20 | 41 198 | 6 532 835 | |
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 330 | 636 435 | −1,44 | 61,72 | −575 848 | 39 280 768 |
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 330 | 645 765 | 1,47 | 10,29 | 96 006 | 6 644 922 | |
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −993 | 636 435 | −0,16 | 62,82 | −62 380 | 39 980 847 |
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 993 | 637 428 | 0,16 | 10,29 | 10 218 | 6 559 134 | |
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −100 | 636 435 | −0,02 | 63,92 | −6 392 | 40 680 925 |
2017-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 100 | 636 535 | 0,02 | 10,29 | 1 029 | 6 549 945 | |
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 423 | 41 682 | −20,00 | ||||
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 327 | 4 039 | −45,17 | ||||
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −715 | 7 366 | −8,85 | ||||
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 327 | 636 435 | −0,52 | 62,02 | −206 341 | 39 471 699 |
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 327 | 639 762 | 0,52 | 10,20 | 33 935 | 6 525 572 | |
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −715 | 636 435 | −0,11 | 62,93 | −44 995 | 40 050 855 |
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 715 | 637 150 | 0,11 | 10,20 | 7 293 | 6 498 930 | |
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 423 | 636 435 | −1,61 | 63,30 | −659 776 | 40 286 336 |
2017-04-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 423 | 646 858 | 1,64 | 10,29 | 107 253 | 6 656 169 | |
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 423 | 52 105 | −16,67 | ||||
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 818 | 8 081 | −25,86 | ||||
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 224 | 10 899 | −10,10 | ||||
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 818 | 636 435 | −0,44 | 67,65 | −190 638 | 43 054 828 |
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 818 | 639 253 | 0,44 | 10,20 | 28 744 | 6 520 381 | |
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 224 | 636 435 | −0,19 | 67,88 | −83 085 | 43 201 208 |
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 224 | 637 659 | 0,19 | 10,20 | 12 485 | 6 504 122 | |
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 423 | 636 435 | −1,61 | 68,17 | −710 536 | 43 385 774 |
2017-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 423 | 646 858 | 1,64 | 10,29 | 107 253 | 6 656 169 | |
2017-02-14 |
|
5 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −800 | 636 435 | −0,13 | 62,61 | −50 088 | 39 847 195 | |
2017-02-14 |
|
5 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −1 600 | 637 235 | −0,25 | 65,09 | −104 144 | 41 477 626 | |
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −100 | 62 528 | −0,16 | ||||
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 323 | 62 628 | −14,15 | ||||
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 042 | 12 123 | −25,00 | ||||
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −100 | 636 435 | −0,02 | 62,51 | −6 251 | 39 783 552 |
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 100 | 636 535 | 0,02 | 10,29 | 1 029 | 6 549 945 | |
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 323 | 636 435 | −1,60 | 61,69 | −636 826 | 39 261 675 |
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 323 | 646 758 | 1,62 | 10,29 | 106 224 | 6 655 140 | |
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 042 | 636 435 | −0,63 | 61,13 | −247 087 | 38 905 272 |
2017-02-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 042 | 640 477 | 0,64 | 10,20 | 41 228 | 6 532 865 | |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 053 | 72 951 | −9,94 | ||||
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 180 | 81 004 | −2,62 | ||||
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −190 | 83 184 | −0,23 | ||||
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −200 | 16 165 | −1,22 | ||||
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 842 | 16 365 | −19,01 | ||||
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −200 | 638 835 | −0,03 | 55,26 | −11 052 | 35 302 022 |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 200 | 639 035 | 0,03 | 10,20 | 2 040 | 6 518 157 | |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 842 | 638 835 | −0,60 | 57,40 | −220 531 | 36 669 129 |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 842 | 642 677 | 0,60 | 10,20 | 39 188 | 6 555 305 | |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 053 | 638 835 | −1,24 | 57,89 | −466 188 | 36 982 158 |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 053 | 646 888 | 1,26 | 10,29 | 82 865 | 6 656 478 | |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 180 | 638 835 | −0,34 | 58,86 | −128 315 | 37 601 828 |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 180 | 641 015 | 0,34 | 10,29 | 22 432 | 6 596 044 | |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −190 | 638 835 | −0,03 | 59,68 | −11 339 | 38 125 673 |
2017-01-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 190 | 639 025 | 0,03 | 10,29 | 1 955 | 6 575 567 | |
2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 423 | 83 374 | −11,11 | ||||
2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 042 | 20 207 | −16,67 | ||||
2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 042 | 638 835 | −0,63 | 65,70 | −265 577 | 41 974 206 |
2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 042 | 642 877 | 0,63 | 10,20 | 41 228 | 6 557 345 | |
2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 423 | 638 835 | −1,61 | 66,35 | −691 568 | 42 386 830 |
2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 423 | 649 258 | 1,63 | 10,29 | 107 253 | 6 680 865 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 310 | 93 797 | −3,41 | ||||
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 113 | 97 107 | −6,82 | ||||
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 600 | 24 249 | −6,19 | ||||
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 442 | 25 849 | −8,63 | ||||
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 310 | 638 835 | −0,52 | 58,26 | −192 832 | 37 216 930 |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 310 | 642 145 | 0,52 | 10,29 | 34 060 | 6 607 672 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 113 | 638 835 | −1,10 | 59,28 | −421 656 | 37 869 883 |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 113 | 645 948 | 1,11 | 10,29 | 73 193 | 6 646 805 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 600 | 638 835 | −0,25 | 56,50 | −90 406 | 36 096 605 |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 600 | 640 435 | 0,25 | 10,20 | 16 320 | 6 532 437 | |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 442 | 638 835 | −0,38 | 57,43 | −140 249 | 36 689 699 |
2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 442 | 641 277 | 0,38 | 10,20 | 24 908 | 6 541 025 | |
2016-10-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 223 | 104 220 | −9,72 | ||||
2016-10-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 242 | 28 291 | −10,28 | ||||
2016-10-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −11 223 | 638 835 | −1,73 | 54,41 | −610 629 | 34 758 182 |
2016-10-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 11 223 | 650 058 | 1,76 | 10,29 | 115 485 | 6 689 097 | |
2016-10-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 242 | 638 835 | −0,50 | 54,41 | −176 393 | 34 758 182 |
2016-10-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 242 | 642 077 | 0,51 | 10,20 | 33 068 | 6 549 185 | |
2016-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −6 148 | 0 | −100,00 | ||||
2016-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −31 269 | 115 443 | −21,31 | ||||
2016-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −31 269 | 638 835 | −4,67 | 50,08 | −1 565 977 | 31 993 368 |
2016-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 31 269 | 648 307 | 5,07 | 10,29 | 321 758 | 6 671 079 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 042 | 31 533 | −11,36 | ||||
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 411 | 0 | −100,00 | ||||
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 200 | 5 411 | −28,91 | ||||
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −1 973 | 0 | −100,00 | ||||
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −10 331 | 0 | −100,00 | ||||
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 411 | 617 038 | −0,87 | 45,91 | −248 432 | 28 329 695 |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 411 | 622 449 | 0,88 | 4,45 | 24 079 | 2 769 898 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 200 | 617 038 | −0,36 | 45,15 | −99 335 | 27 860 685 |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 200 | 619 238 | 0,36 | 4,45 | 9 790 | 2 755 609 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 042 | 617 038 | −0,65 | 44,84 | −181 240 | 27 667 490 |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 042 | 621 080 | 0,66 | 10,20 | 41 228 | 6 335 016 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 973 | 617 038 | 0,32 | 10,29 | 20 302 | 6 349 321 | |
2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 331 | 615 065 | 1,71 | 10,20 | 105 376 | 6 273 663 | |
2016-09-06 |
|
4 | MIRN |
Mirna Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2016-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 177 793 | 177 793 | |||||
2016-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 207 | 2 207 | |||||
2016-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 72 000 | 604 734 | 13,52 | ||||
2016-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −23 381 | 532 734 | −4,20 | 46,59 | −1 089 337 | 24 820 450 |
2016-08-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 042 | 35 575 | −10,20 | ||||
2016-08-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 618 | 7 611 | −50,02 | ||||
2016-08-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 618 | 556 115 | −1,35 | 47,33 | −360 568 | 26 321 535 |
2016-08-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 618 | 563 733 | 1,37 | 4,45 | 33 900 | 2 508 612 | |
2016-08-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 042 | 556 115 | −0,72 | 46,92 | −189 644 | 26 091 970 |
2016-08-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 042 | 560 157 | 0,73 | 10,20 | 41 228 | 5 713 601 | |
2016-07-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 042 | 39 617 | −9,26 | ||||
2016-07-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 042 | 556 115 | −0,72 | 45,20 | −182 718 | 25 139 123 |
2016-07-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 042 | 560 157 | 0,73 | 10,20 | 41 228 | 5 713 601 | |
2016-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 446 | 15 229 | −13,84 | ||||
2016-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 172 | 17 675 | −22,64 | ||||
2016-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 446 | 556 115 | −0,44 | 40,10 | −98 085 | 22 300 212 |
2016-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 446 | 558 561 | 0,44 | 4,45 | 10 885 | 2 485 596 | |
2016-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 172 | 556 115 | −0,92 | 40,78 | −210 914 | 22 678 370 |
2016-07-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 172 | 561 287 | 0,93 | 4,45 | 23 015 | 2 497 727 | |
2016-06-14 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Employee Stock Option (Right to Buy) |
A - Award | 3 750 | 3 750 | |||||
2016-06-14 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Common Stock |
A - Award | 1 875 | 1 875 | |||||
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 423 | 146 712 | −6,63 | ||||
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 042 | 43 659 | −8,47 | ||||
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 618 | 22 847 | −25,01 | ||||
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 618 | 556 115 | −1,35 | 43,22 | −329 250 | 24 035 290 |
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 618 | 563 733 | 1,37 | 4,45 | 33 900 | 2 508 612 | |
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 042 | 556 115 | −0,72 | 43,66 | −176 474 | 24 279 981 |
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 042 | 560 157 | 0,73 | 10,20 | 41 228 | 5 713 601 | |
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 423 | 556 115 | −1,84 | 43,84 | −456 944 | 24 380 082 |
2016-06-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 423 | 566 538 | 1,87 | 10,29 | 107 253 | 5 829 676 | |
2016-06-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 792 | 157 135 | −6,43 | ||||
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 792 | 556 115 | −1,90 | 40,10 | −432 810 | 22 302 825 |
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 792 | 566 907 | 1,94 | 10,29 | 111 050 | 5 833 473 | |
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 130 | 167 927 | −0,67 | ||||
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 130 | 556 115 | −0,20 | 40,07 | −45 284 | 22 285 919 |
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 130 | 557 245 | 0,20 | 10,29 | 11 628 | 5 734 051 | |
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −28 970 | 169 057 | −14,63 | ||||
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 768 | 47 701 | −14,00 | ||||
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −28 970 | 556 115 | −4,95 | 40,51 | −1 173 589 | 22 528 497 |
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 28 970 | 585 085 | 5,21 | 10,29 | 298 101 | 6 020 525 | |
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 768 | 556 115 | −1,38 | 40,51 | −314 686 | 22 528 497 |
2016-05-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 768 | 563 883 | 1,40 | 10,20 | 79 234 | 5 751 607 | |
2016-05-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 700 | 55 469 | −2,97 | ||||
2016-05-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 700 | 556 115 | −0,30 | 40,00 | −68 000 | 22 244 600 |
2016-05-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 700 | 557 815 | 0,31 | 10,20 | 17 340 | 5 689 713 | |
2016-05-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 700 | 57 169 | −10,49 | ||||
2016-05-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 700 | 556 115 | −1,19 | 40,12 | −268 777 | 22 309 109 |
2016-05-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 700 | 562 815 | 1,20 | 10,20 | 68 340 | 5 740 713 | |
2016-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 618 | 30 465 | −20,00 | ||||
2016-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 618 | 556 115 | −1,35 | 35,16 | −267 849 | 19 553 003 |
2016-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 618 | 563 733 | 1,37 | 4,45 | 33 900 | 2 508 612 | |
2016-04-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −800 | 63 869 | −1,24 | ||||
2016-04-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −800 | 556 115 | −0,14 | 40,00 | −32 000 | 22 244 600 |
2016-04-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 800 | 556 915 | 0,14 | 10,20 | 8 160 | 5 680 533 | |
2016-04-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 618 | 38 083 | −16,67 | ||||
2016-04-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 618 | 556 115 | −1,35 | 36,12 | −275 162 | 20 086 874 |
2016-04-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 618 | 563 733 | 1,37 | 4,45 | 33 900 | 2 508 612 | |
2016-03-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 954 | 45 701 | −19,33 | ||||
2016-03-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −900 | 556 115 | −0,16 | 36,14 | −32 522 | 20 095 549 |
2016-03-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 054 | 557 015 | −1,77 | 35,69 | −358 795 | 19 878 083 |
2016-03-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 954 | 567 069 | 1,97 | 4,45 | 48 745 | 2 523 457 | |
2016-03-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 282 | 56 655 | −7,03 | ||||
2016-03-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 282 | 556 115 | −0,76 | 35,01 | −149 913 | 19 469 586 |
2016-03-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 282 | 560 397 | 0,77 | 4,45 | 19 055 | 2 493 767 | |
2015-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 720 | 0 | −100,00 | ||||
2015-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 720 | 556 115 | −0,66 | 39,99 | −148 763 | 22 239 039 |
2015-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 720 | 559 835 | 0,67 | 5,63 | 20 944 | 3 151 871 | |
2015-11-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −87 473 | 556 115 | −13,59 | 45,40 | −3 970 951 | 25 245 563 | |
2015-11-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 718 | 3 720 | −49,99 | ||||
2015-11-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 718 | 643 588 | −0,57 | 43,14 | −160 395 | 27 764 386 |
2015-11-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 718 | 647 306 | 0,58 | 5,63 | 20 932 | 3 644 333 | |
2015-10-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −18 202 | 0 | −100,00 | ||||
2015-10-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −14 063 | 0 | −100,00 | ||||
2015-10-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 18 202 | 643 588 | 2,91 | 5,63 | 102 477 | 3 623 400 | |
2015-10-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 14 063 | 625 386 | 2,30 | 4,45 | 62 580 | 2 782 968 | |
2015-10-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 718 | 7 438 | −33,33 | ||||
2015-10-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 718 | 611 323 | −0,60 | 41,30 | −153 541 | 25 245 561 |
2015-10-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 718 | 615 041 | 0,61 | 5,63 | 20 932 | 3 462 681 | |
2015-09-30 |
|
4 | MIRN |
Mirna Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 12 000 | 12 000 | |||||
2015-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 718 | 11 156 | −25,00 | ||||
2015-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 718 | 611 323 | −0,60 | 40,12 | −149 166 | 24 526 279 |
2015-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 718 | 615 041 | 0,61 | 5,63 | 20 932 | 3 462 681 | |
2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 157 446 | 157 446 | |||||
2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 554 | 2 554 | |||||
2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 64 000 | 611 323 | 11,69 | ||||
2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −31 754 | 525 268 | −5,70 | 42,02 | −1 334 440 | 22 074 020 |
2015-08-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 718 | 14 874 | −20,00 | ||||
2015-08-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 718 | 557 022 | −0,66 | 46,91 | −174 411 | 26 129 902 |
2015-08-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 718 | 560 740 | 0,67 | 5,63 | 20 932 | 3 156 966 | |
2015-07-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 718 | 18 592 | −16,67 | ||||
2015-07-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 718 | 557 022 | −0,66 | 46,94 | −174 515 | 26 145 443 |
2015-07-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 718 | 560 740 | 0,67 | 5,63 | 20 932 | 3 156 966 | |
2015-06-22 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
A - Award | 7 500 | 7 500 | |||||
2015-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 718 | 22 310 | −14,28 | ||||
2015-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 718 | 557 022 | −0,66 | 45,72 | −169 971 | 25 464 595 |
2015-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 718 | 560 740 | 0,67 | 5,63 | 20 932 | 3 156 966 | |
2015-05-21 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 6 350 | 6 350 | |||||
2015-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −20 000 | 4 444 | −81,82 | 39,97 | −799 418 | 177 631 | |
2015-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −18 181 | 0 | −100,00 | ||||
2015-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −18 181 | 24 444 | −42,65 | 35,04 | −637 077 | 856 537 | |
2015-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 181 | 42 625 | 74,38 | 0,33 | 6 000 | 14 066 | |
2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −52 052 | 26 028 | −66,66 | ||||
2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −52 052 | 557 022 | −8,55 | 40,65 | −2 116 080 | 22 644 727 |
2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 52 052 | 609 074 | 9,34 | 5,63 | 293 053 | 3 429 087 | |
2015-02-13 |
|
5 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −2 688 | 557 022 | −0,48 | ||||
2015-01-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 804 | 0 | −100,00 | ||||
2015-01-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −16 804 | 559 710 | −2,91 | 31,80 | −534 320 | 17 797 211 |
2015-01-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 16 804 | 576 514 | 3,00 | 5,92 | 99 480 | 3 412 963 | |
2014-09-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 600 | 16 804 | −25,00 | ||||
2014-09-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 600 | 559 710 | −0,99 | 42,54 | −238 224 | 23 810 063 |
2014-09-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 600 | 565 310 | 1,00 | 5,92 | 33 152 | 3 346 635 | |
2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 147 732 | 147 732 | |||||
2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 268 | 2 268 | |||||
2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 60 000 | 559 710 | 12,01 | ||||
2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −25 507 | 499 710 | −4,86 | 43,55 | −1 110 804 | 21 761 871 |
2014-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 500 | 22 404 | −27,50 | ||||
2014-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 500 | 525 217 | −1,59 | 40,48 | −344 090 | 21 261 414 |
2014-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 500 | 533 717 | 1,62 | 5,92 | 50 320 | 3 159 605 | |
2014-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 700 | 30 904 | −8,03 | ||||
2014-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 700 | 525 217 | −0,51 | 40,05 | −108 130 | 21 033 890 |
2014-08-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 700 | 527 917 | 0,51 | 5,92 | 15 984 | 3 125 269 | |
2014-07-17 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
A - Award | 7 500 | 7 500 | |||||
2014-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 200 | 33 604 | −25,00 | ||||
2014-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −11 200 | 525 217 | −2,09 | 40,14 | −449 574 | 21 082 473 |
2014-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 11 200 | 536 417 | 2,13 | 5,92 | 66 304 | 3 175 589 | |
2014-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −325 479 | 525 217 | −38,26 | ||||
2014-06-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −5 000 | 1 038 554 | −0,48 | ||||
2014-05-15 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Series D Preferred Stock |
C - Conversion | −13 256 | 0 | −100,00 | ||||
2014-05-15 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Series B Preferred Stock |
C - Conversion | −11 188 | 0 | −100,00 | ||||
2014-05-15 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 24 444 | 24 444 | |||||
2014-04-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 600 | 44 804 | −11,11 | ||||
2014-04-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 600 | 955 696 | −0,58 | 43,34 | −242 702 | 41 419 578 |
2014-04-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 600 | 961 296 | 0,59 | 5,92 | 33 152 | 5 690 872 | |
2014-03-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 600 | 50 404 | −10,00 | ||||
2014-03-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 718 | 78 080 | −4,55 | ||||
2014-03-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 600 | 955 696 | −0,58 | 52,89 | −296 164 | 50 543 417 |
2014-03-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 600 | 961 296 | 0,59 | 5,92 | 33 152 | 5 690 872 | |
2014-03-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 718 | 955 696 | −0,39 | 52,89 | −196 632 | 50 543 417 |
2014-03-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 718 | 959 414 | 0,39 | 5,63 | 20 932 | 5 401 501 | |
2014-02-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −100 000 | 955 696 | −9,47 | 51,97 | −5 197 010 | 49 667 617 | |
2014-02-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −12 142 | 0 | −100,00 | ||||
2014-02-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 12 142 | 1 055 696 | 1,16 | 10,33 | 125 427 | 10 905 340 | |
2014-02-03 |
|
4 | RARE |
Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy) |
A - Award | 17 500 | 17 500 | |||||
2014-01-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 858 | 0 | −100,00 | ||||
2014-01-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 858 | 1 043 554 | −0,18 | 39,27 | −72 957 | 40 976 504 |
2014-01-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 1 858 | 1 045 412 | 0,18 | 10,33 | 19 193 | 10 799 106 | |
2013-12-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −18 996 | 0 | −100,00 | ||||
2013-12-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 18 996 | 1 043 554 | 1,85 | 5,92 | 112 456 | 6 177 840 | |
2013-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 1 858 | −51,84 | ||||
2013-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 024 558 | −0,19 | 41,25 | −82 492 | 42 258 714 |
2013-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 026 558 | 0,20 | 10,33 | 20 660 | 10 604 344 | |
2013-11-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 3 858 | −34,14 | ||||
2013-11-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 024 558 | −0,19 | 38,63 | −77 254 | 39 575 602 |
2013-11-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 026 558 | 0,20 | 10,33 | 20 660 | 10 604 344 | |
2013-10-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 5 858 | −25,45 | ||||
2013-10-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 024 558 | −0,19 | 43,87 | −87 732 | 44 943 261 |
2013-10-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 026 558 | 0,20 | 10,33 | 20 660 | 10 604 344 | |
2013-09-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 7 858 | −20,29 | ||||
2013-09-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −100 000 | 977 211 | −9,28 | 43,92 | −4 392 270 | 42 921 746 | |
2013-09-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 077 211 | −0,19 | 42,77 | −85 532 | 46 067 898 |
2013-09-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 079 211 | 0,19 | 10,33 | 20 660 | 11 148 250 | |
2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 135 064 | 135 064 | 41,04 | 5 543 027 | 5 543 027 | ||
2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 436 | 2 436 | 41,04 | 99 973 | 99 973 | ||
2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 55 000 | 1 124 558 | 5,14 | ||||
2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 653 | 1 069 558 | −0,71 | 40,91 | −313 084 | 43 755 618 |
2013-08-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 9 858 | −16,87 | ||||
2013-08-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 077 211 | −0,19 | 40,03 | −80 063 | 43 122 372 |
2013-08-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 079 211 | 0,19 | 10,33 | 20 660 | 11 148 250 | |
2013-07-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 11 858 | −14,43 | ||||
2013-07-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 077 211 | −0,19 | 32,59 | −65 186 | 35 109 646 |
2013-07-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 079 211 | 0,19 | 10,33 | 20 660 | 11 148 250 | |
2013-06-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 13 858 | −12,61 | ||||
2013-06-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 077 211 | −0,19 | 33,88 | −67 762 | 36 496 878 |
2013-06-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 079 211 | 0,19 | 10,33 | 20 660 | 11 148 250 | |
2013-05-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 15 858 | −11,20 | ||||
2013-05-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 077 211 | −0,19 | 36,58 | −73 153 | 39 400 393 |
2013-05-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 079 211 | 0,19 | 10,33 | 20 660 | 11 148 250 | |
2013-04-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 17 858 | −10,07 | ||||
2013-04-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 077 211 | −0,19 | 35,53 | −71 062 | 38 274 169 |
2013-04-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 079 211 | 0,19 | 10,33 | 20 660 | 11 148 250 | |
2013-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −68 750 | 1 077 211 | −6,00 | 28,87 | −1 984 950 | 31 101 236 | |
2013-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 19 858 | −9,15 | ||||
2013-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −25 000 | 1 145 961 | −2,13 | 28,31 | −707 820 | 32 445 365 | |
2013-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 170 961 | −0,17 | 28,12 | −56 247 | 32 931 639 |
2013-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 172 961 | 0,17 | 10,33 | 20 660 | 12 116 687 | |
2013-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 21 858 | −8,38 | ||||
2013-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 170 961 | −0,17 | 29,61 | −59 216 | 34 669 813 |
2013-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 172 961 | 0,17 | 10,33 | 20 660 | 12 116 687 | |
2013-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 23 858 | −7,73 | ||||
2013-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 170 961 | −0,17 | 25,05 | −50 104 | 29 334 915 |
2013-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 172 961 | 0,17 | 10,33 | 20 660 | 12 116 687 | |
2013-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 249 | 0 | −100,00 | ||||
2013-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 249 | 1 170 961 | −0,53 | 23,83 | −148 939 | 27 908 802 |
2013-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 249 | 1 177 210 | 0,53 | 3,30 | 20 622 | 3 884 793 | |
2012-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 250 | 4 249 | −66,01 | ||||
2012-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 250 | 1 170 961 | −0,70 | 25,19 | −207 777 | 29 490 770 |
2012-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 250 | 1 179 211 | 0,70 | 3,30 | 27 225 | 3 891 396 | |
2012-11-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 27 858 | −6,70 | ||||
2012-11-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 250 | 12 499 | −33,34 | ||||
2012-11-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 170 961 | −0,17 | 25,51 | −51 025 | 29 873 908 |
2012-11-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 172 961 | 0,17 | 10,33 | 20 660 | 12 116 687 | |
2012-11-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 250 | 1 170 961 | −0,53 | 25,51 | −159 452 | 29 873 908 |
2012-11-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 250 | 1 177 211 | 0,53 | 3,30 | 20 625 | 3 884 796 | |
2012-10-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 29 858 | −6,28 | ||||
2012-10-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 250 | 18 749 | −25,00 | ||||
2012-10-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 170 961 | −0,17 | 26,59 | −53 174 | 31 132 574 |
2012-10-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 172 961 | 0,17 | 10,33 | 20 660 | 12 116 687 | |
2012-10-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 250 | 1 170 961 | −0,53 | 26,59 | −166 170 | 31 132 574 |
2012-10-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 250 | 1 177 211 | 0,53 | 3,30 | 20 625 | 3 884 796 | |
2012-09-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 31 858 | −5,91 | ||||
2012-09-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 250 | 24 999 | −20,00 | ||||
2012-09-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 170 961 | −0,17 | 26,54 | −53 081 | 31 077 773 |
2012-09-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 172 961 | 0,17 | 10,33 | 20 660 | 12 116 687 | |
2012-09-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 250 | 1 170 961 | −0,53 | 26,54 | −165 878 | 31 077 773 |
2012-09-06 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 250 | 1 177 211 | 0,53 | 3,30 | 20 625 | 3 884 796 | |
2012-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 181 794 | 181 794 | 26,10 | 4 744 823 | 4 744 823 | ||
2012-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 3 831 | 3 831 | 26,10 | 99 989 | 99 989 | ||
2012-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 74 250 | 1 170 961 | 6,77 | ||||
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −458 | 31 249 | −1,44 | ||||
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −458 | 1 096 711 | −0,04 | 25,22 | −11 550 | 27 657 955 |
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 458 | 1 097 169 | 0,04 | 3,30 | 1 511 | 3 620 658 | |
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 33 858 | −5,58 | ||||
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 792 | 31 707 | −15,45 | ||||
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 096 711 | −0,18 | 26,04 | −52 082 | 28 559 451 |
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 098 711 | 0,18 | 10,33 | 20 660 | 11 349 685 | |
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 792 | 1 096 711 | −0,53 | 26,04 | −150 829 | 28 559 451 |
2012-08-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 792 | 1 102 503 | 0,53 | 3,30 | 19 114 | 3 638 260 | |
2012-07-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 35 858 | −5,28 | ||||
2012-07-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 250 | 37 499 | −14,29 | ||||
2012-07-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 000 | 1 096 711 | −0,18 | 25,36 | −50 715 | 27 810 069 |
2012-07-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 000 | 1 098 711 | 0,18 | 10,33 | 20 660 | 11 349 685 | |
2012-07-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 250 | 1 096 711 | −0,57 | 25,36 | −158 486 | 27 810 069 |
2012-07-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 250 | 1 102 961 | 0,57 | 3,30 | 20 625 | 3 639 771 | |
2012-07-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
G - Gift | −5 000 | 1 096 711 | −0,45 | ||||
2012-01-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2012-01-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −15 000 | 1 045 055 | −1,42 | 16,73 | −250 959 | 17 484 397 |
2012-01-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 15 000 | 1 060 055 | 1,44 | 6,34 | 95 100 | 6 720 749 | |
2006-02-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 81 798 | 81 798 | 5,63 | 460 523 | 460 523 | ||
2006-02-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 18 202 | 18 202 | 5,63 | 102 477 | 102 477 |